HIV molecular immunology database

 

Patient Detail

Patient Code 014A-004
Patient Sex Male
Risk Factor Sex with male (SM)
Infection Country US
Infection City
Infection Year
HLA Type A*02:01, A*11:01, B*40:02, B*51:01, C*02:02, C*14:02
Patient Ethnicity White
Progression
Species human
Patient Note Subject 014A-004, 35 years old, who participated in a vaccine trial, acquired HIV within 242 days of administration of vaccine vCP205, 4 times. Response to epitopes Pol TAFTIPSI, Gag CTERQANFL, Gag SLYNTVATL and Nef AVDLSHFLK by EliSpot was 210, 70, 149 and 740 SFC/106 PBMC, 46d post-infection (dpi). [Horton2006a, PMID: 16973582]. Additional HLA-C alleles from authors (pers comm., J.McNevin, 2021).
CTL CD8+ Records 54940, 54941, 54942, 54943, 62526
T-Helper CD4+ Records
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health